The global cell expansion market is projected to exceed US$39,256.2 million by 2030

SEATTLE, September 21, 2022 /PRNewswire/ — According to Coherent market insightsthe globe cell expansion market is appreciated $16,035.5 million in 2022 and is expected to issue a CAGR of 11.8% during the forecast period (2022-2030).

Important trends and analyses Global Cell Extension Market:

The major market trends include increasing investments by biotechnology products market players, increasing product launches by major players, commitment to stem cell manufacturing by major market players, etc.

Increasing investments by cell and gene therapy related biotechnology products market players are expected to propel the growth of the global cell expansion market during the forecast period. For example in February 2022FUJIFILM Corporation, a Japan-based multinational conglomerate, announced the launch of its life sciences strategic investment fund managed by Life Sciences Corporate Venture Capital (LS-CVC), a newly formed entity under Fujifilm’s Life Sciences Strategy Headquarters in Tokyo. Fujifilm is investing US$54 million that will focus on cutting-edge biotechnology through partnerships with emerging companies worldwide. In addition to this new fund, the LS-CVC will assume management of the company’s previous life science investment portfolio, which included investments in regenerative medicine, cell therapies and drug development research products.

An increasing number of product launches related to antimicrobial therapies are expected to propel the growth of the global cell expansion market during the forecast period. For example in October 2020, Merck, a leading global research and technology company, has launched a new VirusExpress production platform for lentiviral products, based on Merck’s experience as a contract development and manufacturing company. This new platform can overcome hurdles in lentiviral production and reduce process development time by approximately 40%. Merck’s VirusExpress platform streamlines the upstream process, making it easier to manage, modify and scale cell and gene therapy development.

Request a sample copy of this report @ https://www.coherentmarketinsights.com/insight/request-sample/1293

The introduction of dedicated stem cell production and expansion facilities is expected to propel the growth of the global cell expansion market over the forecast period. For example in April 2022, Ncardia, a leader in contract research, development and manufacturing of induced pluripotent stem cell (iPSC) based solutions, launched Cellistic, a CDMO (Contract Development and Manufacturing Organization) for iPSC cell therapy. Cellistic is focused on the development and manufacturing of human iPSC-based cell therapies. Celletic’s expertise and focus on iPSC reprogramming, differentiation and expansion makes the company an ideal partner for innovative cell therapy developers looking to commercialize new advanced therapies.

Key market takeaways:

Market players are involved in the introduction of automated cell bulk culture equipment and are expected to further impel the growth of the global cell expansion market during the forecast period. For example in March 2019Hitachi, Ltd., a Japan-based multinational company, announced the launch of automated cell mass culture equipment in Japanused to produce commercial induced pluripotent stem cells (iPSCs) for regenerative medicine.

Among the regions North America is expected to occupy a dominant position in the world cell expansion market during the forecast period due to increasing product launches in the region. in the July 2020, Corning Incorporated, a US-based multinational technology company, announced the launch of the Corning X-SERIES cell processing platform. The platform enables rapid, sterile, automated, and efficient processing of human blood and blood products to obtain purified immune cell populations for cell and gene therapy applications.

Some of the major players in the global cell extension market are: Becton, Dickinson and Company, Sartorius AG, Merck KGaA, Corning, Inc., Eppendorf SE, Lonza Group AG, PromoCell, Danaher, Thermo Fisher Scientific, HiMedia Laboratories, STEMCELL Technologies Inc., REPROCELL Inc., Bio-Techne, Valiant Co ., Ltd., Miltenyi Biotec, Biologos, Cyagen US Inc.

Customization request @ https://www.coherentmarketinsights.com/insight/request-customization/1293

Detailed segmentation:

Global Cell Extension Market, by Product:

  • consumables
  • instruments
    • Automated cell
    • extension systems
    • cell counter
    • centrifuges
    • bioreactors
    • Other
  • Accesories

Global Cell Extension Market, by Cell Type:

  • mammalian cells
    • human cells
      • stem cells
      • adult stem cells
      • Induced pluripotent stem cells
      • Embryonic Stem Cells
    • differentiated cells
    • Animal cells
  • microbial cells
  • Other (plant-derived cells)

Global Cell Extension Market by Application:

  • biopharmaceuticals
  • Tissue Culture & Engineering
  • vaccine production
  • drug development
  • cancer research
  • stem cell research
  • Other Applications

Global Cell Extension Market by End-User:

  • biotechnology company
  • Biopharmaceutical Companies
  • Other

Global Cell Extension Market by Regions:

  • North America
  • Europe
    • By country:
      • United Kingdom
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • the rest of Europe
      • Asia Pacific
    • By country:
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • the rest of Asia Pacific
  • Latin America
    • By country:
      • Brazil
      • Mexico
      • Argentina
      • the rest of Latin America
  • middle East & Africa
    • By country:
      • GCC countries
      • Israel
      • South Africa
      • the rest of middle East & Africa

Buy this full report now @ https://www.coherentmarketinsights.com/insight/buy-now/1293

About us:

Coherent market insights is a global market research and consulting organization focused on helping our multitude of clients achieve transformative growth by helping them make critical business decisions. We are headquartered in Indiawith sales office at Global Financial Capital in the USA and sales consultants in United Kingdom and Japan. Our customer base includes players from various industries in over 57 countries worldwide. We create value for our customers through our highly reliable and accurate reports. We are also committed to playing a leadership role in providing post-COVID-19 insights across multiple sectors and continue to deliver measurable, sustainable outcomes for our clients.

Contact us:
Lord Shah
Senior Client Partner – Business Development
Coherent market insights
Phone:
US: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
E-mail: sales@coherentmarketinsights.com
Website: https://www.coherentmarketinsights.com
Follow us: LinkedIn | Twitter

Logo: https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

SOURCE Coherent market insights

Leave a Comment